Innate Pharma S.A. (EPA:IPH)
1.616
-0.004 (-0.25%)
Sep 26, 2025, 5:35 PM CET
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
€72,621
Profits / Employee
€264,661
Market Cap
148.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
ABIVAX Société Anonyme | 69 |
Virbac | 6,365 |
Innate Pharma News
- 10 days ago - This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Benzinga
- 10 days ago - IPHA: Leerink Partners Downgrades Innate Pharma, Lowers Price Target | IPHA Stock News - GuruFocus
- 10 days ago - Innate Pharma (IPHA) Downgrade: What Investors Need to Know | IPHA Stock News - GuruFocus
- 10 days ago - Innate Pharma SA (IPHA) (H1 2025) Earnings Call Highlights: Strategic Focus and Financial ... - GuruFocus
- 10 days ago - Half Year 2025 Innate Pharma SA Earnings Call Transcript - GuruFocus
- 11 days ago - Innate Pharma S.A. GAAP EPS of -€0.25, revenue of €4.9M - Seeking Alpha
- 11 days ago - Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Innate Pharma S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha